News
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US. The bold move has been ...
Washington D.C: US President Donald Trump has unveiled a new luxury fragrance collection titled “Victory 45-47”, symbolising ...
This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth ...
Mobile apps bypass Apple's 30% fee with web payments. Case studies show up to 190% revenue increases using proven frameworks.
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
NORTHAMPTON, MA / ACCESS Newswire / June 24, 2025 /Originally published in GoDaddy's 2024 Sustainability Report Employee ...
Makeda, 33, shed four stone after learning to manage her busy lifestyle, which sees her juggling three children - including ...
Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss ...
Building and marketing a mobile app is hard; turning that hard work into profit is even harder. Until recently, developers unwilling to surrender up to 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results